Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7339 p259
5 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Good business case needed for independent sector to provide primary care services

Government proposals to encourage the independent sector to provide services in primary care will only happen if there is a good business case, the Company Chemists Association warned this week.

CCA members are concerned that the opportunities for the private sector to have a greater influence in primary care, created by the new community pharmacy and GP contracts and practice based commissioning, will be thwarted by primary care trusts.

The CCA complains that PCTs are historically reluctant to take risks, are fearful of any radical change and are motivated by meeting short-term political targets.

Its comments follow a discussion document, “The future shape of a primary care and general practice”, published this week by the NHS Alliance — the leading representative organisation for primary care trusts.

The CCA argues that PCTs need to commission services from a wider range of providers, not only GPs, and open their eyes to innovation. “This will allow the NHS to benefit from the novel perspective the private sector can bring to primary care. There is scepticism about whether PCTs actually have the courage to commission services from private providers, and defy the politics of vested interest,” it said.

The CCA also wants to see broader representation on PCTs’ professional executive committees, including the private sector, to help boost innovation and entrepreneurship.

The National Pharmaceutical Association is a member of the NHS Alliance’s allied health professions and primary care practitioners and health networks, and contributed to the Alliance report.

NPA head of NHS service development Karen Homan said: “We recognise that there are an awful lot of opportunities for community pharmacists to develop new services in line with primary care provision. However there are a number of stumbling blocks and barriers which need to be overcome. One of the issues is that, historically, PCTs are used to commissioning with GPs and not others and do not think of the wider health care team.”

The report by the NHS Alliance was drawn up on the back of the raft of Government reforms for primary care. The Alliance said the changes would be “radical” but the problem for PCTs was their ability to challenge the status quo without “creating chaos”. PCTs were particularly concerned that the reforms meant that primary care was moving from a “near-monopoly” of service providers to a plurality of provision which could destabilise the system.

Back to Top


©The Pharmaceutical Journal